{"id":"danazol-once-weekly","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"8%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1479","moleculeType":"Small molecule","molecularWeight":"337.46"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Danazol acts by binding to the androgen receptor, thereby inhibiting the transcription of androgen-dependent genes.","oneSentence":"Androgen receptor antagonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:00.252Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Endometriosis"},{"name":"Fibrocystic breast disease"}]},"trialDetails":[{"nctId":"NCT00758953","phase":"PHASE2","title":"Pain Associated With Endometriosis","status":"COMPLETED","sponsor":"Lumara Health, Inc.","startDate":"2007-02","conditions":"Endometriosis","enrollment":66}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Danazol Once Weekly","genericName":"Danazol Once Weekly","companyName":"Lumara Health, Inc.","companyId":"lumara-health-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Danazol Once Weekly is a small molecule that acts as a progesterone receptor agonist, classified as an agonist. It has been studied as a treatment for endometriosis, with a clinical trial (NCT00758953) completed in 2012 to evaluate its efficacy in this condition.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}